Bora Pharmaceuticals Co., LTD. (TPE:6472)
Taiwan
· Delayed Price · Currency is TWD 733.00
+25.00 (3.53%)
May 14, 2025, 1:30 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Commercial Sales | 12.97B |
Log In |
Log In |
Log In |
Log In |
| Commercial Sales Growth | 40.38% |
Log In |
Log In |
Log In |
Log In |
| Contract Development and Manufacturing Organization of Pharmaceuticals | 6.27B |
Log In |
Log In |
Log In |
Log In |
| Contract Development and Manufacturing Organization of Pharmaceuticals Growth | 26.68% |
Log In |
Log In |
Log In |
Log In |
| Other | 8.67M |
Log In |
Log In |
Log In |
Log In |
| Other Growth | -35.72% |
Log In |
Log In |
Log In |
Log In |
| Other | 8.67M |
Log In |
Log In |
Log In |
Log In |
| Other Growth | -35.72% |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Other | 246.83M |
Log In |
Log In |
Log In |
Log In |
| Other Growth | 122.51% |
Log In |
Log In |
Log In |
Log In |
| United States | 15.44B |
Log In |
Log In |
Log In |
Log In |
| United States Growth | 40.95% |
Log In |
Log In |
Log In |
Log In |
| Europe | 2.13B |
Log In |
Log In |
Log In |
Log In |
| Europe Growth | 2.28% |
Log In |
Log In |
Log In |
Log In |
| Taiwan | 1.43B |
Log In |
Log In |
Log In |
Log In |
| Taiwan Growth | 35.73% |
Log In |
Log In |
Log In |
Log In |
| Other | 246.83M |
Log In |
Log In |
Log In |
Log In |
| Other Growth | 122.51% |
Log In |
Log In |
Log In |
Log In |